DBVTF: DBV Technologies S.A. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 54.03
Book Value / Share 0.40
Price / Book n/a
NCAV ($M) 6.12
NCAV / Share 0.04
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -1.87
Return on Assets (ROA) -0.78
Return on Equity (ROE) -1.02

Liquidity (mrq)
Quick Ratio 1.43
Current Ratio 1.43

Balance Sheet (mrq) ($M)
Current Assets 44.39
Assets 65.66
Liabilities 38.27
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4.20
Operating Income -116.50
Net Income -113.90

Cash Flow Statement (mra) ($M)
Cash From Operations -104.50
Cash from Investing -0.80
Cash from Financing 0.60

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
CVSI – CV Sciences, Inc. CYAN – Cyanotech Corporation
CYDY – CytoDyn Inc. DMKPQ – DMK Pharmaceuticals Corporation
DRNK – NOHO, Inc.


Financial data and stock pages provided by
Fintel.io